-
Study aim
-
To investigate the effect of canola-Pistacia Atlantica seeds oil (a blend of canola and Pistacia Atlantica seed oils compared with canola–corn oil with TBHQ and canola–corn oil without TBHQ on serum oxidant and antioxidant status markers in patients with metabolic syndrome.
-
Design
-
Three way randomized cross-over clinical trial
-
Settings and conduct
-
This study will be conducted at the school of Public health. all three oils will be provided in the same packages labeled by a person not aware of the study objectives. Participants and personnel will be blinded to the intervention oil.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Males and females aged 20-50 years and with at least three of 5 metabolic syndrome conditions.
Exclusion criteria: history of cardiovascular diseases, diabetes, cancer, liver, kidney, gastrointestinal disease, changing blood glucose and lipid profile control medications in previous 3 months, taking corticosteroids, androgens, phenytoin, erythromycin, hemostatic regulators (other than Asprin), and gastrointestinal medication in last 30 days, alcohol consumption, pregnancy, giving birth in last 12 months, smoking, omega-3 supplement use >1 g/day, severe weight change in previous 3 months, not willing to enter or follow the study protocol
-
Intervention groups
-
Each intervention period (phase) will last 8 weeks. The participants will receive canola-Pistacia Atlantica seed oil, canola–corn oil (with TBHQ), and canola–corn oil (without TBHQ) in each intervention period. Intervention periods will be separated with 4 weeks of washout periods (sunflower oil will be provided).
-
Main outcome variables
-
Serum total antioxidant capacity, Total oxidant capacity, malondialdehyde, myeloperoxidase , superoxide dismutase , catalase , glutathione peroxidase, glutathione reductase, and nitric oxide levels